Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model
Weam W. Ibrahim, Ahmed S. Kamel, Ahmed Wahid, et al.
Inflammopharmacology (2022) Vol. 30, Iss. 6, pp. 2505-2520
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 82
Unveiling the interplay of AMPK/SIRT1/PGC-1α axis in brain health: Promising targets against aging and NDDs
Pratik Shankar Rakshe, Bhaskar Jyoti Dutta, Shivani Chib, et al.
Ageing Research Reviews (2024) Vol. 96, pp. 102255-102255
Closed Access | Times Cited: 23
The GLP-1 Agonist Semaglutide Ameliorates Cognitive Regression in P301S Tauopathy Mice Model via Autophagy/ACE2/SIRT1/FOXO1-Mediated Microglia Polarization
Norhan N. Elbadawy, Muhammed A. Saad, Sara Elfarrash, et al.
European Journal of Pharmacology (2025), pp. 177305-177305
Closed Access | Times Cited: 2
Neuroprotective potential of Erigeron bonariensis ethanolic extract against ovariectomized/D-galactose-induced memory impairments in female rats in relation to its metabolite fingerprint as revealed using UPLC/MS
Weam W. Ibrahim, Rabab H. Sayed, Mohamed F. Abdelhameed, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 2, pp. 1091-1112
Open Access | Times Cited: 9
Danshensu sodium salt alleviates muscle atrophy via CaMKII‐PGC1α‐FoxO3a signaling pathway in D‐galactose‐induced models
Pooreum Lim, Seung-Hwan Woo, JiHye Han, et al.
The FASEB Journal (2025) Vol. 39, Iss. 2
Open Access | Times Cited: 1
NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model
Weam W. Ibrahim, Krystyna Skalicka‐Woźniak, Barbara Budzyńska, et al.
International Immunopharmacology (2023) Vol. 119, pp. 110239-110239
Closed Access | Times Cited: 22
Dapagliflozin Ameliorates Cognitive Impairment in Aluminum-Chloride-Induced Alzheimer’s Disease via Modulation of AMPK/mTOR, Oxidative Stress and Glucose Metabolism
Waad A. Samman, Salma Selim, Hassan M. El Fayoumi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 5, pp. 753-753
Open Access | Times Cited: 18
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Keren Esther Kristina Mantik, Sujin Kim, Bonsang Gu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11450-11450
Open Access | Times Cited: 17
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
cAMP-PKA signaling pathway and anxiety: Where do we go next?
Daokang Chen, Jingji Wang, Jian Cao, et al.
Cellular Signalling (2024) Vol. 122, pp. 111311-111311
Closed Access | Times Cited: 7
Empagliflozin mitigates type 2 diabetes-associated peripheral neuropathy: a glucose-independent effect through AMPK signaling
Noha F. Abdelkader, Marawan A. Elbaset, Passant E. Moustafa, et al.
Archives of Pharmacal Research (2022) Vol. 45, Iss. 7, pp. 475-493
Open Access | Times Cited: 26
The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation
Bo Pang, Lulu Zhang, Bin Li, et al.
Physiology & Behavior (2023) Vol. 263, pp. 114134-114134
Closed Access | Times Cited: 12
Drugs repurposing in the experimental models of Alzheimer’s disease
Sheer A. Joodi, Weam W. Ibrahim, Mahmoud M. Khattab
Inflammopharmacology (2025)
Open Access
Exploring the Therapeutic Role of Flavonoids Through AMPK Activation in Metabolic Syndrome: A Narrative Review
Lunasmrita Saikia, Narayan Chandra Talukdar, Partha Dutta
Phytotherapy Research (2025)
Closed Access
Okra seed polysaccharides mitigate neuroinflammation and cognitive impairment via modulation of Nrf2/HO-1, HMGB1/RAGE/TLR4/NF-κB, NLRP3/Caspase-1, JAK-2/STAT-3, AMPK/SIRT1/m-TOR, PI3K/AKT/CREB/BDNF/TrkB and PERK/CHOP/Bcl-2 axes
Jilan A. Nazeam, Ian Black, Varughese A Mulamoottil, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114110-114110
Closed Access
Targeting Lkb1-Ampk-Sirt1-Induced Autophagy and Mitophagy Pathways Improve Cerebrovascular Homeostasis in App/Ps1 Mice
Yawen Li, Yifan Wu, Tongxing Wang, et al.
(2025)
Closed Access
Dapagliflozin Improves High‐Fat Diet‐Induced Cognitive Impairment in Female Mice
Xiaolin Pang, Mingxia Fan, Zhuoni Xiao, et al.
Brain and Behavior (2025) Vol. 15, Iss. 2
Open Access
Modulating Multiple Molecular Trajectories by Nutraceuticals and/or Physical Activity in Attention-Deficit/Hyperactivity Disorder (ADHD)-Like Behaviors in Rat Pups
Karema Abu‐Elfotuh, Gellan Alaa Mohamed Kamel, Mazin A. A. Najm, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Open Access
Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction
Nattayaporn Apaijai, Tanawat Attachaipanich, Chayodom Maneechote, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167809-167809
Closed Access
Targeting LKB1–AMPK–SIRT1–induced autophagy and mitophagy pathways improves cerebrovascular homeostasis in APP/PS1 mice
Yawen Li, Tongxing Wang, Hong-Rong Li, et al.
Free Radical Biology and Medicine (2025)
Closed Access
Dapagliflozin Ameliorate Type-2 Diabetes Associated Neuropathy via Regulation of IGF-1R Signaling
Prabhsimran Kaur, Tashvinder Singh, Laxmipriya Jena, et al.
Journal of Neuroimmune Pharmacology (2025) Vol. 20, Iss. 1
Closed Access
Association of antidiabetic medications with depression risk and All-Cause mortality in type 2 Diabetes: A TriNetX-Based cohort study
I‐Chieh Chen, Yen‐Wei Pai, Jun‐Fu Lin, et al.
Diabetes Research and Clinical Practice (2025), pp. 112167-112167
Open Access
Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCζ-mediated neurogenesis
Radwa N. Muhammad, Mohammed A. Albahairy, Mai A. Abd El Fattah, et al.
Psychopharmacology (2024) Vol. 241, Iss. 12, pp. 2565-2584
Open Access | Times Cited: 3
Recent Advances of Mitochondrial Alterations in Alzheimer’s Disease: A Perspective of Mitochondrial Basic Events
Wenyan Wei, Ying Jiang, Guizhen Hu, et al.
Journal of Alzheimer s Disease (2024) Vol. 101, Iss. 2, pp. 379-396
Closed Access | Times Cited: 3
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials
Zonglin Li, Chu Lin, Xiaoling Cai, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top